Authors:
Shohat, M
Hodak, E
Sredni, B
Shohat, B
Sredni, D
David, M
Citation: M. Shohat et al., Cytokine profile of patients with mycosis fungoides and the immunomodulatory effect of AS101, ACT DER-VEN, 81(4), 2001, pp. 255-257
Citation: E. Hodak et M. Feinmesser, Histopathologic features of progression in mediterranean and immunodeficiency-related Kaposi sarcoma - Authors' reply, AM J DERMAT, 22(1), 2000, pp. 90-91
Authors:
Hodak, E
Hammel, I
Feinmesser, M
Zelinger, A
Maron, L
Sulkes, J
David, M
Citation: E. Hodak et al., Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma, AM J DERMAT, 21(2), 1999, pp. 138-145
Authors:
Feinmesser, M
Halpern, M
Fenig, E
Tsabari, C
Hodak, E
Sulkes, J
Brenner, B
Okon, E
Citation: M. Feinmesser et al., Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: Can they predict treatment response and clinical outcome?, HUMAN PATH, 30(11), 1999, pp. 1367-1372
Authors:
Shohat, M
Hodak, E
Hannig, H
Bodemer, W
David, M
Shohat, B
Citation: M. Shohat et al., Evidence for the cofactor role of human T-cell lymphotropic virus type 1 in mycosis fungoides and Sezary syndrome, BR J DERM, 141(1), 1999, pp. 44-49
Authors:
Yosipovitch, G
Mevorah, B
David, M
Feinmesser, M
Hodak, E
Gabay, B
Ammash, J
Elias, PM
Citation: G. Yosipovitch et al., Migratory ichthyosiform dermatosis with type 2 diabetes mellitus and insulin resistance, ARCH DERMAT, 135(10), 1999, pp. 1237-1242